Previously, Amgen filed patent infringement lawsuits against biosimilar companies including the Swiss Sandoz, South Korea's Celltrion, South Korea's Samsung Bioepis, and Germany's Fresenius Kabi.
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback